ID   TTC-1240
AC   CVCL_8002
SY   TTC1240; TTC 1240
DR   BioSample; SAMN10989626
DR   Cell_Model_Passport; SIDM01459
DR   Cosmic; 801772
DR   Cosmic; 802055
DR   Cosmic; 2144783
DR   DepMap; ACH-001210
DR   GEO; GSM2409670
DR   GEO; GSM2409671
DR   GEO; GSM2409672
DR   GEO; GSM2409673
DR   GEO; GSM2409674
DR   GEO; GSM2409675
DR   GEO; GSM2409706
DR   GEO; GSM2495986
DR   GEO; GSM2495988
DR   GEO; GSM2787354
DR   Wikidata; Q54973230
RX   PubMed=10602515;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=24418192;
RX   PubMed=28945250;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; p.Glu216Ter (c.646G>T); Zygosity=Unspecified (PubMed=10602515; PubMed=11921280; PubMed=28945250).
CC   Omics: Deep exome analysis.
CC   Omics: H3K27ac ChIP-seq epigenome analysis.
CC   Omics: H3K27me3 ChIP-seq epigenome analysis.
CC   Omics: H3K4me1 ChIP-seq epigenome analysis.
CC   Omics: H3K4me3 ChIP-seq epigenome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Misspelling: TTC1204; Cosmic=801772.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
RX   PubMed=10602515; DOI=10.1038/sj.onc.1203168;
RA   DeCristofaro M.F., Betz B.L., Wang W.-D., Weissman B.E.;
RT   "Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and
RT   primary rhabdomyosarcomas but not Wilms' tumors.";
RL   Oncogene 18:7559-7565(1999).
//
RX   PubMed=11921280; DOI=10.1002/gcc.10052;
RA   Uno K., Takita J., Yokomori K., Tanaka Y., Ohta S., Shimada H.,
RA   Gilles F.H., Sugita K., Abe S., Sako M., Hashizume K., Hayashi Y.;
RT   "Aberrations of the hSNF5/INI1 gene are restricted to malignant
RT   rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric
RT   solid tumors.";
RL   Genes Chromosomes Cancer 34:33-41(2002).
//
RX   PubMed=12210830; DOI=10.1002/jnr.10330;
RA   Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.;
RT   "Malignant rhabdoid tumor shows incomplete neural characteristics as
RT   revealed by expression of SNARE complex.";
RL   J. Neurosci. Res. 69:642-652(2002).
//
RX   PubMed=24418192; DOI=10.1111/cas.12352;
RA   Takita J., Chen Y.-Y., Kato M., Ohki K., Sato Y., Ohta S., Sugita K.,
RA   Nishimura R., Hoshino N., Seki M., Sanada M., Oka A., Hayashi Y.,
RA   Ogawa S.;
RT   "Genome-wide approach to identify second gene targets for malignant
RT   rhabdoid tumors using high-density oligonucleotide microarrays.";
RL   Cancer Sci. 105:258-264(2014).
//
RX   PubMed=28945250; DOI=10.1038/ng.3958;
RA   Nakayama R.T., Pulice J.L., Valencia A.M., McBride M.J.,
RA   McKenzie Z.M., Gillespie M.A., Ku W.L., Teng M.-X., Cui K.-R.,
RA   Williams R.T., Cassel S.H., Qing H., Widmer C.J., Demetri G.D.,
RA   Irizarry R.A., Zhao K.-J., Ranish J.A., Kadoch C.;
RT   "SMARCB1 is required for widespread BAF complex-mediated activation of
RT   enhancers and bivalent promoters.";
RL   Nat. Genet. 49:1613-1623(2017).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//